SEC Form 4 · accession 0001193125-26-359255
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David L Mahoney
Director
Period of report
Aug 18, 2026
Accepted (ET)
Aug 20, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 18, 2026 | S | 4,984 | $117.4716 | D | 1,232,161 | I | Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust |
| Common StockF3 | Aug 18, 2026 | S | 91,167 | $118.2376 | D | 1,140,994 | I | Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust |
| Common StockF4 | Aug 18, 2026 | S | 7,055 | $118.8817 | D | 1,133,939 | I | Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust |
| Common StockF5 | Aug 18, 2026 | S | 400 | $119.6381 | D | 1,133,539 | I | Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust |
| Common Stock | holding | — | — | — | 26,147 | I | The Black Dog Private Foundation |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on May 11, 2026 in effect at the time of this transaction.
- F2Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.595 to $117.59. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
- F3Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $117.60 to $118.595. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
- F4Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $118.60 to $119.345. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
- F5Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $119.605 to $119.6775. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Remarks
The power of attorney under which this form was signed is on file with the Commission.